SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending due to a mix of factors, including a reported record demand for its $25B bond sale aimed at funding AI expansion, and discussions around Zuckerberg's hints at selling compute power. Community chatter revolves around whether the AI spending is justified and if the stock's dip presents a buying opportunity, with some citing the company's cheap valuation compared to its peers. Despite positive revenue, a one-time tax bill seems to be weighing on sentiment.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is trending as investors anticipate the company's earnings report, with debates swirling around potential IV crush and the impact of ad revenue performance. Community members are weighing bullish predictions against concerns of a possible pullback, influenced by Meta's recent performance. Discussions also include the potential for a Google AI deal to boost the stock.

Why Queen Kitty ($QKitty) Is The Meme Token You’ve Been Waiting For  Queen Kitty isn’t just another hype project—this is a real movement with substance and community power!  Why hold $QKitty? 😼 Real dev, real builds: No fake teams, no copy-paste code. Everything you see is made from scratch. 💧 Working Faucet: Free QKitty for the community. Want to know how? Just ask! 🏆 Big Buy Competition Bot: See top buyers live, fight for the throne, and win rewards! 🎮 Multi-token P2E game coming soon: Play and earn across Web, iOS, Android! 🐾 NFT collecting soon: Cutest collection in crypto, bringing perks and more ways to earn.  Queen Kitty means innovation, transparency, and real delivery for holders. Curious? Join the chat and ask anything!  $QKitty: By the community, for the community. To the moon, together! 🚀🐱

Queen Kitty

Queen Kitty ($QKITTY) is trending amid discussions about its upcoming DEX and SWAP features, with the community expressing excitement for potential updates and passively earning interest via its trading bot. Despite some users reporting losses, the overall sentiment is optimistic, particularly within the Solana ecosystem.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle ($CMG) is trending downwards as discussions center on a recent sales outlook cut and concerns about slowing customer traffic, particularly among younger, lower-income demographics. Community sentiment is mixed, with some viewing the dip as a buying opportunity while others cite issues like high prices, shrinking portions, and inconsistent quality as reasons for the decline. The broader context involves concerns about consumer spending and potential recessionary pressures affecting the restaurant sector.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed buyout rumors, with some traders citing a STAT News report about the company being in talks for a deal. The community is actively debating the validity of these rumors and potential acquisition prices. Some investors also point to the company's pipeline beyond COVID-19 vaccines and short squeeze potential as reasons for optimism.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as investors discuss potential connections with NVDA, fueled by rumors of meetings in Korea and NVDA's interest in small-cap investments. The community is also focused on the company's reaffirmed guidance for 2025 and beyond, along with the potential impact of a significant contract, while some express frustration over the stock's current low price and trading patterns.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions is trending amid increased FY25 EBITDA guidance, leading to community discussions around potential re-rating and short squeeze scenarios. Bullish investors are pointing to the company's perceived undervaluation and are hoping to see a short squeeze. Some community members believe that this stock is a feel good story because it is saving lives.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific (CORZ) is trending due to shareholder discussions surrounding the pending merger with CoreWeave (CRWV). Many community members express concern that the all-stock offer undervalues CORZ, especially given the company's potential in AI infrastructure, while some believe the deal provides stability and growth opportunities. The rejection of the deal could lead to a repricing, but also carries risks associated with current management and future contracts.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members discuss the potential for a short squeeze, driven by high short interest and optimism around the company's pipeline. Chatter revolves around buyout speculation, comparisons to competitors, and anticipation for upcoming presentations at ObesityWeek. The stock's recent performance and market dynamics in the obesity treatment sector are also fueling the conversation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

TDOC is trending as investors discuss its potential for a turnaround, citing undervaluation and upcoming earnings as potential catalysts. Community members are weighing in on potential buyouts, AI integration, and the impact of broader market forces on the stock. Discussions also highlight the company's large user base and significant cash flow, fueling speculation about future growth and value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The insecticide and herbicide maker projected 2025 revenue between $3.92 billion and $4.02 billion, compared with its previous forecast of $4.08 billion and $4.28 billion.</li><li>FMC said pricing is expected to have a mid-to-high single-digit percentage-point impact on its full-year earnings, as it continues to grapple with a high influx of generic products.</li><li>The company also recorded approximately $510 million in charges and write-downs in the third quarter as part of its plans to divest its commercial operations in India.</li></ul>FMC Corp (FMC) stock fell 26.3% in extended trading on Wednesday after the company lowered its full-year forecasts and slashed its dividend to rein in costs.The insecticide and herbicide maker projected 2025 revenue of $3.92 billion to $4.02 billion, down from its previous forecast of $4.08 billion to $4.28 billion. FMC also cut its earnings per share forecast to $2.92 to $3.14, down from $3.26 to $3.70 earlier.Its third-quarter adjusted earnings of $0.89 per share topped estimates of $0.85 per share, according to Fiscal.ai data. However, adjusted quarterly revenue of $961 million fell short of estimates of $1.06 billion.<h2 class="st-heading-2">Why Did FMC Trim Its 2025 Outlook?</h2>FMC said that pricing is expected to be a mid-to-high single-digit percentage point impact on its full-year earnings, as it continues to grapple with a high influx of generic products, which is hampering the sales of the company’s proprietary products. Its Latin America sales fell 8% compared to a year earlier in the third quarter.<blockquote>"Our results reflect the challenges we're facing, most prominently in Latin America. Despite this, our new active ingredients nearly doubled in the quarter and remain central to our strategy," said FMC CEO Pierre Brondeau in a statement.</blockquote>The company added that low customer liquidity caused credit constraints in Brazil and Argentina, further inhibiting growth. Prices of key crops such as soybeans and corn have remained under pressure for much of the year, prompting farmers to cut spending on insecticides and fungicides.The company also recorded approximately $510 million in charges and write-downs in the third quarter as part of its plans to divest its commercial operations in India due to challenges in the country. It also slashed its quarterly dividend by 86% to $0.08 to focus on debt reduction.<h2 class="st-heading-2">What Is Retail Thinking?</h2>Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/FMC">FMC</a> stock was still in the ‘extremely bullish’ territory at the time of writing, compared with ‘bearish’ a day ago.<figure class="image"><img style="aspect-ratio:788/100;" src="https://news.stocktwits-cdn.com/FMC_Oct_29_JPG_8b56026324.webp" alt="FMC’s Sentiment Meter and Message Volume as of 10:27 p.m. ET on Oct. 29, 2025 | Source: Stocktwits" width="788" height="100"><figcaption>FMC’s Sentiment Meter and Message Volume as of 10:27 p.m. ET on Oct. 29, 2025 | Source: Stocktwits</figcaption></figure>“This is pretty shocking after-hours action. Looking forward to a recovery, but [it] may take a while,” one user wrote.<stembedurl>https://stocktwits.com/MrNotSoNice/message/634244264</stembedurl>Some traders were also fine with the dividend cut and saw it as a buying opportunity, hoping sales would improve after the current three-month cycle.<stembedurl>https://stocktwits.com/ABACABB/message/634233562</stembedurl>FMC stock has fallen 40% this year, compared with 11.1% gains in rival Corteva’s shares. The latter firm is separating its seed and pesticide businesses as part of a strategic realignment in response to current market conditions.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/openai-ipo-could-be-the-biggest-ever-aiming-for-a-whopping-1-trillion/cLGFXW3R3D9">OpenAI IPO Could Be The Biggest Ever, Aiming For A Whopping $1 Trillion Valuation: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the FMC Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Did Insecticide Maker FMC Corp’s Stock Tumble Over 26% After-Hours?

FMC cut its earnings per share forecast to $2.92 to $3.14, down from $3.26 to $3.70 earlier.

Equity

FMC Corporation Announces Leadership Change

FMC Corporation Announces Leadership Change FMC Corporation Announces Leadership Change PR Newswire PHILADELPHIA, Oct. 29, 2025 Ronaldo Pereira to depart after 28 years with the company PHILADELPHIA...

FMC Corporation Reports Third Quarter Results

FMC Corporation Reports Third Quarter Results FMC Corporation Reports Third Quarter Results PR Newswire PHILADELPHIA, Oct. 29, 2025 Company reports Adjusted EBITDA and Adjusted EPS above guidance...

FMC (FMC) Earnings Expected to Grow: Should You Buy?

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is FMC (FMC) Up 0.7% Since Last Earnings Report?

FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FMC (FMC) Reliance on International Sales: What Investors Need to Know

Examine the evolution of FMC's (FMC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

FMC vs. CTVA: Which Stock Is the Better Value Option?

FMC (FMC) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

FMC's Earnings Surpass Estimates in Q2 on Higher Volumes

FMC posts better-than-expected Q2 results as higher volumes offset price declines.

FMC (FMC) Q2 Earnings and Revenues Beat Estimates

FMC (FMC) delivered earnings and revenue surprises of +16.95% and +8.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

Current Price	$16.77
Prev Close	$29.04
Open	$21.89
Dividend Yield	4.77%
50-Day Moving Average	$34.31
Beta	0.80
Avg. Volume	1.97M
PE Ratio	36.86

52-Week High	$67.75
52-Week Low	$28.71
Market Capitalization	$3.63B
EPS (Annual)	$2.71
Price to Book	0.82
Revenue Per Employee	$744,929.82
Enterprise Value/EBITDA	N/A

FMC
FMC Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FMC News

FMCFMC Corp.